Summary

The global Celiac Disease Drug market size is predicted to grow from US$ 877 million in 2025 to US$ 2076 million in 2031; it is expected to grow at a CAGR of 15.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Celiac Disease Drug Industry Forecast” looks at past sales and reviews total world Celiac Disease Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Celiac Disease Drug sales for 2025 through 2031. With Celiac Disease Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celiac Disease Drug industry.
This Insight Report provides a comprehensive analysis of the global Celiac Disease Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celiac Disease Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celiac Disease Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celiac Disease Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celiac Disease Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Celiac Disease Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Distension
Diarrhea
Anorexia
Others
Segmentation by Application:
First Line of Treatment
Second Line of Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Celiac Disease Drug market?
What factors are driving Celiac Disease Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celiac Disease Drug market opportunities vary by end market size?
How does Celiac Disease Drug break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celiac Disease Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Celiac Disease Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Celiac Disease Drug by Country/Region, 2020, 2024 & 2031
2.2 Celiac Disease Drug Segment by Type
2.2.1 Distension
2.2.2 Diarrhea
2.2.3 Anorexia
2.2.4 Others
2.3 Celiac Disease Drug Sales by Type
2.3.1 Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Celiac Disease Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Celiac Disease Drug Sale Price by Type (2020-2025)
2.4 Celiac Disease Drug Segment by Application
2.4.1 First Line of Treatment
2.4.2 Second Line of Treatment
2.5 Celiac Disease Drug Sales by Application
2.5.1 Global Celiac Disease Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Celiac Disease Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Celiac Disease Drug Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Celiac Disease Drug Breakdown Data by Company
3.1.1 Global Celiac Disease Drug Annual Sales by Company (2020-2025)
3.1.2 Global Celiac Disease Drug Sales Market Share by Company (2020-2025)
3.2 Global Celiac Disease Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Celiac Disease Drug Revenue by Company (2020-2025)
3.2.2 Global Celiac Disease Drug Revenue Market Share by Company (2020-2025)
3.3 Global Celiac Disease Drug Sale Price by Company
3.4 Key Manufacturers Celiac Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celiac Disease Drug Product Location Distribution
3.4.2 Players Celiac Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Celiac Disease Drug by Geographic Region
4.1 World Historic Celiac Disease Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Celiac Disease Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Celiac Disease Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Celiac Disease Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Celiac Disease Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Celiac Disease Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Celiac Disease Drug Sales Growth
4.4 APAC Celiac Disease Drug Sales Growth
4.5 Europe Celiac Disease Drug Sales Growth
4.6 Middle East & Africa Celiac Disease Drug Sales Growth
5 Americas
5.1 Americas Celiac Disease Drug Sales by Country
5.1.1 Americas Celiac Disease Drug Sales by Country (2020-2025)
5.1.2 Americas Celiac Disease Drug Revenue by Country (2020-2025)
5.2 Americas Celiac Disease Drug Sales by Type (2020-2025)
5.3 Americas Celiac Disease Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celiac Disease Drug Sales by Region
6.1.1 APAC Celiac Disease Drug Sales by Region (2020-2025)
6.1.2 APAC Celiac Disease Drug Revenue by Region (2020-2025)
6.2 APAC Celiac Disease Drug Sales by Type (2020-2025)
6.3 APAC Celiac Disease Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Celiac Disease Drug by Country
7.1.1 Europe Celiac Disease Drug Sales by Country (2020-2025)
7.1.2 Europe Celiac Disease Drug Revenue by Country (2020-2025)
7.2 Europe Celiac Disease Drug Sales by Type (2020-2025)
7.3 Europe Celiac Disease Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celiac Disease Drug by Country
8.1.1 Middle East & Africa Celiac Disease Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Celiac Disease Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Celiac Disease Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Celiac Disease Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celiac Disease Drug
10.3 Manufacturing Process Analysis of Celiac Disease Drug
10.4 Industry Chain Structure of Celiac Disease Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celiac Disease Drug Distributors
11.3 Celiac Disease Drug Customer
12 World Forecast Review for Celiac Disease Drug by Geographic Region
12.1 Global Celiac Disease Drug Market Size Forecast by Region
12.1.1 Global Celiac Disease Drug Forecast by Region (2026-2031)
12.1.2 Global Celiac Disease Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Celiac Disease Drug Forecast by Type (2026-2031)
12.7 Global Celiac Disease Drug Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Information
13.1.2 F. Hoffmann-La Roche Celiac Disease Drug Product Portfolios and Specifications
13.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 F. Hoffmann-La Roche Main Business Overview
13.1.5 F. Hoffmann-La Roche Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Celiac Disease Drug Product Portfolios and Specifications
13.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Celiac Disease Drug Product Portfolios and Specifications
13.3.3 Merck Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Celiac Disease Drug Product Portfolios and Specifications
13.4.3 Pfizer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 ADMA Biologics
13.5.1 ADMA Biologics Company Information
13.5.2 ADMA Biologics Celiac Disease Drug Product Portfolios and Specifications
13.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ADMA Biologics Main Business Overview
13.5.5 ADMA Biologics Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Celiac Disease Drug Product Portfolios and Specifications
13.6.3 Amgen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Anthera Pharmaceuticals
13.7.1 Anthera Pharmaceuticals Company Information
13.7.2 Anthera Pharmaceuticals Celiac Disease Drug Product Portfolios and Specifications
13.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Anthera Pharmaceuticals Main Business Overview
13.7.5 Anthera Pharmaceuticals Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Celiac Disease Drug Product Portfolios and Specifications
13.8.3 Bayer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Biogen
13.9.1 Biogen Company Information
13.9.2 Biogen Celiac Disease Drug Product Portfolios and Specifications
13.9.3 Biogen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biogen Main Business Overview
13.9.5 Biogen Latest Developments
13.10 BioLineRx
13.10.1 BioLineRx Company Information
13.10.2 BioLineRx Celiac Disease Drug Product Portfolios and Specifications
13.10.3 BioLineRx Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 BioLineRx Main Business Overview
13.10.5 BioLineRx Latest Developments
13.11 Biotest
13.11.1 Biotest Company Information
13.11.2 Biotest Celiac Disease Drug Product Portfolios and Specifications
13.11.3 Biotest Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Biotest Main Business Overview
13.11.5 Biotest Latest Developments
13.12 Bristol-Myers Squibb
13.12.1 Bristol-Myers Squibb Company Information
13.12.2 Bristol-Myers Squibb Celiac Disease Drug Product Portfolios and Specifications
13.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Bristol-Myers Squibb Main Business Overview
13.12.5 Bristol-Myers Squibb Latest Developments
13.13 Celgene
13.13.1 Celgene Company Information
13.13.2 Celgene Celiac Disease Drug Product Portfolios and Specifications
13.13.3 Celgene Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Celgene Main Business Overview
13.13.5 Celgene Latest Developments
13.14 Takeda Pharmaceutical
13.14.1 Takeda Pharmaceutical Company Information
13.14.2 Takeda Pharmaceutical Celiac Disease Drug Product Portfolios and Specifications
13.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Takeda Pharmaceutical Main Business Overview
13.14.5 Takeda Pharmaceutical Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Celiac Disease Drug Product Portfolios and Specifications
13.15.3 Novartis Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 LFB Group
13.16.1 LFB Group Company Information
13.16.2 LFB Group Celiac Disease Drug Product Portfolios and Specifications
13.16.3 LFB Group Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 LFB Group Main Business Overview
13.16.5 LFB Group Latest Developments
13.17 Kedrion Biopharma
13.17.1 Kedrion Biopharma Company Information
13.17.2 Kedrion Biopharma Celiac Disease Drug Product Portfolios and Specifications
13.17.3 Kedrion Biopharma Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Kedrion Biopharma Main Business Overview
13.17.5 Kedrion Biopharma Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Celiac Disease Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Celiac Disease Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Distension
Table 4. Major Players of Diarrhea
Table 5. Major Players of Anorexia
Table 6. Major Players of Others
Table 7. Global Celiac Disease Drug Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
Table 9. Global Celiac Disease Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Celiac Disease Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Celiac Disease Drug Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Celiac Disease Drug Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Celiac Disease Drug Sale Market Share by Application (2020-2025)
Table 14. Global Celiac Disease Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Celiac Disease Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Celiac Disease Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Celiac Disease Drug Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Celiac Disease Drug Sales Market Share by Company (2020-2025)
Table 19. Global Celiac Disease Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Celiac Disease Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Celiac Disease Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Celiac Disease Drug Producing Area Distribution and Sales Area
Table 23. Players Celiac Disease Drug Products Offered
Table 24. Celiac Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Celiac Disease Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Celiac Disease Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Celiac Disease Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Celiac Disease Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Celiac Disease Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Celiac Disease Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Celiac Disease Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Celiac Disease Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Celiac Disease Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Celiac Disease Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Celiac Disease Drug Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Celiac Disease Drug Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Celiac Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Celiac Disease Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Celiac Disease Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Celiac Disease Drug Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Celiac Disease Drug Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Celiac Disease Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Celiac Disease Drug Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Celiac Disease Drug Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Celiac Disease Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Celiac Disease Drug Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Celiac Disease Drug Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Celiac Disease Drug
Table 54. Key Market Challenges & Risks of Celiac Disease Drug
Table 55. Key Industry Trends of Celiac Disease Drug
Table 56. Celiac Disease Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Celiac Disease Drug Distributors List
Table 59. Celiac Disease Drug Customer List
Table 60. Global Celiac Disease Drug Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Celiac Disease Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Celiac Disease Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Celiac Disease Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Celiac Disease Drug Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Celiac Disease Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Celiac Disease Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Celiac Disease Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Celiac Disease Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Celiac Disease Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Celiac Disease Drug Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Celiac Disease Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Celiac Disease Drug Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global Celiac Disease Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. F. Hoffmann-La Roche Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. F. Hoffmann-La Roche Celiac Disease Drug Product Portfolios and Specifications
Table 76. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. F. Hoffmann-La Roche Main Business
Table 78. F. Hoffmann-La Roche Latest Developments
Table 79. Johnson & Johnson Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Celiac Disease Drug Product Portfolios and Specifications
Table 81. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Merck Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Celiac Disease Drug Product Portfolios and Specifications
Table 86. Merck Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Pfizer Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Celiac Disease Drug Product Portfolios and Specifications
Table 91. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. ADMA Biologics Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. ADMA Biologics Celiac Disease Drug Product Portfolios and Specifications
Table 96. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. ADMA Biologics Main Business
Table 98. ADMA Biologics Latest Developments
Table 99. Amgen Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Amgen Celiac Disease Drug Product Portfolios and Specifications
Table 101. Amgen Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 102. Amgen Main Business
Table 103. Amgen Latest Developments
Table 104. Anthera Pharmaceuticals Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Anthera Pharmaceuticals Celiac Disease Drug Product Portfolios and Specifications
Table 106. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 107. Anthera Pharmaceuticals Main Business
Table 108. Anthera Pharmaceuticals Latest Developments
Table 109. Bayer Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer Celiac Disease Drug Product Portfolios and Specifications
Table 111. Bayer Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 112. Bayer Main Business
Table 113. Bayer Latest Developments
Table 114. Biogen Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Biogen Celiac Disease Drug Product Portfolios and Specifications
Table 116. Biogen Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 117. Biogen Main Business
Table 118. Biogen Latest Developments
Table 119. BioLineRx Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. BioLineRx Celiac Disease Drug Product Portfolios and Specifications
Table 121. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 122. BioLineRx Main Business
Table 123. BioLineRx Latest Developments
Table 124. Biotest Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Biotest Celiac Disease Drug Product Portfolios and Specifications
Table 126. Biotest Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 127. Biotest Main Business
Table 128. Biotest Latest Developments
Table 129. Bristol-Myers Squibb Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Bristol-Myers Squibb Celiac Disease Drug Product Portfolios and Specifications
Table 131. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 132. Bristol-Myers Squibb Main Business
Table 133. Bristol-Myers Squibb Latest Developments
Table 134. Celgene Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Celgene Celiac Disease Drug Product Portfolios and Specifications
Table 136. Celgene Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 137. Celgene Main Business
Table 138. Celgene Latest Developments
Table 139. Takeda Pharmaceutical Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Takeda Pharmaceutical Celiac Disease Drug Product Portfolios and Specifications
Table 141. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 142. Takeda Pharmaceutical Main Business
Table 143. Takeda Pharmaceutical Latest Developments
Table 144. Novartis Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 145. Novartis Celiac Disease Drug Product Portfolios and Specifications
Table 146. Novartis Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 147. Novartis Main Business
Table 148. Novartis Latest Developments
Table 149. LFB Group Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 150. LFB Group Celiac Disease Drug Product Portfolios and Specifications
Table 151. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 152. LFB Group Main Business
Table 153. LFB Group Latest Developments
Table 154. Kedrion Biopharma Basic Information, Celiac Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 155. Kedrion Biopharma Celiac Disease Drug Product Portfolios and Specifications
Table 156. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 157. Kedrion Biopharma Main Business
Table 158. Kedrion Biopharma Latest Developments


List of Figures
Figure 1. Picture of Celiac Disease Drug
Figure 2. Celiac Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celiac Disease Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Celiac Disease Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Celiac Disease Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Celiac Disease Drug Sales Market Share by Country/Region (2024)
Figure 10. Celiac Disease Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Distension
Figure 12. Product Picture of Diarrhea
Figure 13. Product Picture of Anorexia
Figure 14. Product Picture of Others
Figure 15. Global Celiac Disease Drug Sales Market Share by Type in 2025
Figure 16. Global Celiac Disease Drug Revenue Market Share by Type (2020-2025)
Figure 17. Celiac Disease Drug Consumed in First Line of Treatment
Figure 18. Global Celiac Disease Drug Market: First Line of Treatment (2020-2025) & (K Pcs)
Figure 19. Celiac Disease Drug Consumed in Second Line of Treatment
Figure 20. Global Celiac Disease Drug Market: Second Line of Treatment (2020-2025) & (K Pcs)
Figure 21. Global Celiac Disease Drug Sale Market Share by Application (2024)
Figure 22. Global Celiac Disease Drug Revenue Market Share by Application in 2025
Figure 23. Celiac Disease Drug Sales by Company in 2025 (K Pcs)
Figure 24. Global Celiac Disease Drug Sales Market Share by Company in 2025
Figure 25. Celiac Disease Drug Revenue by Company in 2025 ($ millions)
Figure 26. Global Celiac Disease Drug Revenue Market Share by Company in 2025
Figure 27. Global Celiac Disease Drug Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Celiac Disease Drug Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Celiac Disease Drug Sales 2020-2025 (K Pcs)
Figure 30. Americas Celiac Disease Drug Revenue 2020-2025 ($ millions)
Figure 31. APAC Celiac Disease Drug Sales 2020-2025 (K Pcs)
Figure 32. APAC Celiac Disease Drug Revenue 2020-2025 ($ millions)
Figure 33. Europe Celiac Disease Drug Sales 2020-2025 (K Pcs)
Figure 34. Europe Celiac Disease Drug Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Celiac Disease Drug Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Celiac Disease Drug Revenue 2020-2025 ($ millions)
Figure 37. Americas Celiac Disease Drug Sales Market Share by Country in 2025
Figure 38. Americas Celiac Disease Drug Revenue Market Share by Country (2020-2025)
Figure 39. Americas Celiac Disease Drug Sales Market Share by Type (2020-2025)
Figure 40. Americas Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 41. United States Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Celiac Disease Drug Sales Market Share by Region in 2025
Figure 46. APAC Celiac Disease Drug Revenue Market Share by Region (2020-2025)
Figure 47. APAC Celiac Disease Drug Sales Market Share by Type (2020-2025)
Figure 48. APAC Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 49. China Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. India Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Celiac Disease Drug Sales Market Share by Country in 2025
Figure 57. Europe Celiac Disease Drug Revenue Market Share by Country (2020-2025)
Figure 58. Europe Celiac Disease Drug Sales Market Share by Type (2020-2025)
Figure 59. Europe Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 60. Germany Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. France Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Celiac Disease Drug Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Celiac Disease Drug Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Celiac Disease Drug Sales Market Share by Application (2020-2025)
Figure 68. Egypt Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Celiac Disease Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Celiac Disease Drug in 2025
Figure 74. Manufacturing Process Analysis of Celiac Disease Drug
Figure 75. Industry Chain Structure of Celiac Disease Drug
Figure 76. Channels of Distribution
Figure 77. Global Celiac Disease Drug Sales Market Forecast by Region (2026-2031)
Figure 78. Global Celiac Disease Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Celiac Disease Drug Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Celiac Disease Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Celiac Disease Drug Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Celiac Disease Drug Revenue Market Share Forecast by Application (2026-2031)